首页> 外国专利> THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOTRACER LABELLED ANTIBODIES, DIRECTED AGAINST THE DIFFERENTATION ANTIGEN LIMITED TO HUMAN LYMPHOCYTES B, FOR TREATING LYMPHOMA FROM LYMPHOCYTES B

THERAPEUTIC APPLICATION OF CHIMERIC AND RADIOTRACER LABELLED ANTIBODIES, DIRECTED AGAINST THE DIFFERENTATION ANTIGEN LIMITED TO HUMAN LYMPHOCYTES B, FOR TREATING LYMPHOMA FROM LYMPHOCYTES B

机译：定向于人类淋巴细胞B的分化抗原的嵌合和放射示踪剂标记抗体的治疗性应用，用于治疗淋巴细胞B中的淋巴瘤

页面导航

摘要
著录项
相似文献

摘要

Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies.

机译：本文公开了设计用于治疗B细胞淋巴瘤的治疗方案。这些方案基于治疗策略，包括使用免疫活性的小鼠/人嵌合抗CD20抗体，放射性标记的抗CD20抗体，以及包括使用嵌合抗CD20抗体和放射性标记的抗CD20抗体的协同策略。

著录项

公开/公告号PL174494B1

专利类型
公开/公告日1998-08-31

原文格式PDF
申请/专利权人 IDEC PHARMACEUTICALS CORP;
展开▼

申请/专利号PL19930309002
发明设计人 ANDERSON DARRELL R.;RASTETTER WILLIAM H.;HANNA NABIL;LEONARD JOHN E.;NEWMAN ROLAND A.;REFF MITCHELL E.;
展开▼

申请日1993-11-12
分类号A61K39/395;
国家 PL
入库时间 2022-08-22 02:56:41

相似文献

专利
外文文献
中文文献